Certain embodiments of the invention set forth materials and methods for inhibiting mammalian cell growth by use of a chemical material containing at least one biguanide group, -NH-C(NH)-NH-C(NH)-NH-, in the preparation of, e.g., a medicament or medical device. The chemical material may be, e.g., monomeric or polymeric.